This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
31 May 2011

Sanofi and DNDi Sign Research Collaboration Agreement

In the framework of this agreement, Sanofi will initially bring molecules from its libraries into the partnership, while DNDi and Sanofi collaborate in research activities on innovative molecular scaffolds.

Sanofi and Drugs for Neglected Diseases initiative (DNDi) inked a three-year research collaboration agreement for the research of new treatments for nine neglected tropical diseases (NTDs) listed by the World Health Organization (WHO) for which new, adapted, and efficient tools are urgently needed to treat patients in endemic countries.

 

In the framework of this agreement, Sanofi will initially bring molecules from its libraries into the partnership, while DNDi and Sanofi collaborate in research activities on innovative molecular scaffolds.

 

The core of the agreement lies in the innovative management of intellectual property generated through the collaboration. The rights to results produced by this partnership will be coow

Related News